Clinical trials
Phase 1/2 trials in the Netherlands with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 7 |
| University Medical Center Groningen | 6 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 5 |
| Erasmus Medical Center | 3 |
| Leiden University Medical Center | 3 |
| Fast Forward Pharmaceuticals | 2 |
| SetPoint Medical Corporation | 2 |
| The Netherlands Cancer Institute | 2 |
| Amsterdam UMC, location VUmc | 1 |
| Commissie Voor Klinisch Toegepast Onderzoek | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 3 |
| Crohn Disease | 3 |
| Inflammation | 3 |
| Leukemia | 3 |
| Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Arthritis, Rheumatoid | 2 |
| Atherosclerosis | 2 |
| Gastrointestinal Neoplasms | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.